Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Wave Life Sci Ord Sh (WVE)

Wave Life Sci Ord Sh (WVE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 602,860
  • Shares Outstanding, K 122,284
  • Annual Sales, $ 113,310 K
  • Annual Income, $ -57,510 K
  • 60-Month Beta -1.12
  • Price/Sales 5.23
  • Price/Cash Flow N/A
  • Price/Book 11.65
Trade WVE with:

Options Overview Details

View History
  • Implied Volatility 88.81% ( -4.83%)
  • Historical Volatility 67.12%
  • IV Percentile 57%
  • IV Rank 22.24%
  • IV High 267.01% on 06/27/23
  • IV Low 37.86% on 08/16/23
  • Put/Call Vol Ratio 0.42
  • Today's Volume 186
  • Volume Avg (30-Day) 114
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 3,503
  • Open Int (30-Day) 4,158

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.18
  • Number of Estimates 4
  • High Estimate -0.04
  • Low Estimate -0.24
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.64 +19.39%
on 04/26/24
6.30 -12.00%
on 04/02/24
-0.77 (-12.20%)
since 04/01/24
3-Month
3.50 +58.28%
on 02/14/24
7.67 -27.77%
on 03/07/24
+1.54 (+38.50%)
since 02/01/24
52-Week
3.15 +75.86%
on 05/24/23
7.67 -27.77%
on 03/07/24
+1.71 (+44.64%)
since 05/01/23

Most Recent Stories

More News
2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss

The gene-editing market is moving fast, and it pays to get to know some of these companies.

WVE : 5.64 (+14.40%)
BEAM : 22.57 (+6.36%)
Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates

Wave Life Sciences (WVE) delivered earnings and revenue surprises of -550% and 72.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

WVE : 5.64 (+14.40%)
CRSP : 55.66 (+5.04%)
Wave Life Sciences (WVE) Reports Q4 Loss, Misses Revenue Estimates

Wave Life Sciences (WVE) delivered earnings and revenue surprises of -11.90% and 47.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

WVE : 5.64 (+14.40%)
YMAB : 16.80 (+10.45%)
2seventy bio, Inc. (TSVT) Reports Q4 Loss, Tops Revenue Estimates

2seventy bio, Inc. (TSVT) delivered earnings and revenue surprises of 60.78% and 236.09%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

TSVT : 4.74 (+3.95%)
WVE : 5.64 (+14.40%)
Precision BioSciences (DTIL) Reports Q4 Loss, Tops Revenue Estimates

Precision BioSciences (DTIL) delivered earnings and revenue surprises of -8.33% and 78%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

DTIL : 10.59 (+1.73%)
WVE : 5.64 (+14.40%)
Wave Life Sciences (WVE) Upgraded to Buy: Here's What You Should Know

Wave Life Sciences (WVE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

WVE : 5.64 (+14.40%)
After Plunging -23.26% in 4 Weeks, Here's Why the Trend Might Reverse for Wave Life Sciences (WVE)

Wave Life Sciences (WVE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates...

WVE : 5.64 (+14.40%)
Morphic Holding, Inc. (MORF) Surges 18.7%: Is This an Indication of Further Gains?

Morphic Holding, Inc. (MORF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near...

MORF : 28.27 (+3.67%)
WVE : 5.64 (+14.40%)
The Zacks Analyst Blog Highlights AVEO Pharmaceuticals, Cabaletta Bio, Verona Pharma and Wave Life Sciences

AVEO Pharmaceuticals, Cabaletta Bio, Verona Pharma and Wave Life Sciences are included in this Analyst Blog.

AVEO : 15.00 (unch)
WVE : 5.64 (+14.40%)
VRNA : 15.53 (+0.52%)
CABA : 12.36 (+16.06%)
All You Need to Know About Wave Life Sciences (WVE) Rating Upgrade to Buy

Wave Life Sciences (WVE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

WVE : 5.64 (+14.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

WAVE Life Sciences Pte. Ltd. is a preclinical biopharmaceutical company. It designs, develops and commercializes nucleic acid therapeutic candidates for Huntington's disease, Duchenne muscular dystrophy and inflammatory bowel disease. Huntington's disease, the Company has programs targeting HTT SNP-1...

See More

Key Turning Points

3rd Resistance Point 5.20
2nd Resistance Point 5.07
1st Resistance Point 5.00
Last Price 5.64
1st Support Level 4.80
2nd Support Level 4.67
3rd Support Level 4.60

See More

52-Week High 7.67
Fibonacci 61.8% 5.94
Last Price 5.64
Fibonacci 50% 5.41
Fibonacci 38.2% 4.88
52-Week Low 3.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar